Why GSK (GSK) is a Top Momentum Stock for the Long-Term
https://www.zacks.com/stock/news/2277925/why-gsk-gsk-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2277925
May 23, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
Top Research Reports for Novo Nordisk, QUALCOMM & Caterpillar
https://www.zacks.com/commentary/2277328/top-research-reports-for-novo-nordisk-qualcomm-caterpillar?cid=CS-ZC-FT-research_daily-2277328
May 22, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk (NVO), QUALCOMM (QCOM) and Caterpillar (CAT), as well as two micro-cap stocks CSP Inc. (CSPI) and Epsilon Energy Ltd. (EPSN).
0
GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
https://www.zacks.com/stock/news/2277367/gsk-studies-on-depemokimab-for-severe-asthma-meet-primary-goals?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2277367
May 22, 2024 - GSK's depemokimab has the potential to become the first ultra-long-acting biologic for severe asthma with a six-month dosing schedule
0
GSK faces another Zantac whistleblower lawsuit
https://seekingalpha.com/news/4108481-gsk-faces-another-zantac-whistleblower-lawsuit?source=feed_sector_healthcare
May 20, 2024 - A laboratory files a whistleblower lawsuit against GSK over the alleged presence of the cancer-causing chemical NDMA in heartburn drug Zantac. Read more here.
0
GSK to sell entire Haleon stake
https://seekingalpha.com/news/4107601-gsk-sell-entire-haleon-stake?source=feed_sector_healthcare
May 16, 2024 - GSK (GSK) announces plans to sell its entire stake in consumer care company Haleon, following previous gradual reductions in ownership. Read more here.
0
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
https://www.zacks.com/stock/news/2272961/moderna-mrna-falls-as-fda-extends-review-time-for-rsv-vaccine?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2272961
May 13, 2024 - Moderna's (MRNA) RSV vaccine, mRNA-1345's review timeline gets delayed. A decision is now expected by the end of May.
0
GSK plc (GSK) Q1 2024 Earnings Call Transcript
https://seekingalpha.com/article/4689355-gsk-plc-gsk-q1-2024-earnings-call-transcript?source=feed_sector_transcripts
May 03, 2024 - GSK plc (NYSE:NYSE:GSK) Q1 2024 Earnings Conference Call May 1, 2024 3:00 AM ETCompany ParticipantsNick Stone - Head of Investor RelationsEmma Walmsley -...
0
Why GSK (GSK) is a Top Growth Stock for the Long-Term
https://www.zacks.com/stock/news/2267961/why-gsk-gsk-is-a-top-growth-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2267961
May 03, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
0
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
https://www.cnbc.com/2024/04/30/ftc-challenges-patents-held-by-drugmakers-including-for-ozempic.html
Apr 30, 2024 - The agency sent letters to Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Covis Pharma, GlaxoSmithKline, Novartis, Teva Pharmaceuticals, among others.
0
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
https://www.zacks.com/stock/news/2264363/here-s-how-to-play-pfizer-pfe-stock-ahead-of-q1-earnings?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2264363
Apr 29, 2024 - Pfizer (PFE) expects its operational revenues to improve, driven by its in-line products like Vyndaqel, new launches like Abrysvo and newly acquired products, including those acquired from Seagen.
0